NeuBase Therapeutics (STU:O7P) Other Long Term Assets : €0.12 Mil (As of Sep. 2023)

View and export this data going back to 2019. Start your Free Trial

What is NeuBase Therapeutics Other Long Term Assets?

NeuBase Therapeutics's other long-term assets for the quarter that ended in Sep. 2023 was €0.12 Mil.

NeuBase Therapeutics's quarterly other long-term assets declined from Mar. 2023 (€0.23 Mil) to Jun. 2023 (€0.12 Mil) but then increased from Jun. 2023 (€0.12 Mil) to Sep. 2023 (€0.12 Mil).

NeuBase Therapeutics's annual other long-term assets declined from Sep. 2019 (€0.31 Mil) to Sep. 2020 (€0.12 Mil) but then increased from Sep. 2020 (€0.12 Mil) to Sep. 2021 (€0.35 Mil).

NeuBase Therapeutics Other Long Term Assets Historical Data

The historical data trend for NeuBase Therapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeuBase Therapeutics Other Long Term Assets Chart

NeuBase Therapeutics Annual Data

Trend

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Other Long Term Assets

Get a 7-Day Free Trial

0.01

0.31

0.12

0.35

NeuBase Therapeutics Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Other Long Term Assets	Get a 7-Day Free Trial															0.28	0.26	0.23	0.12	0.12

NeuBase Therapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

NeuBase Therapeutics (STU:O7P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NeuBase Therapeutics Inc (STU:O7P) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

NBSE:USA O7P:Germany

Address

350 Technology Drive, Suite 421, Pittsburgh, PA, USA, 15219

Website

https://www.neubasetherapeutics.com

NeuBase Therapeutics Inc is a pre-clinical stage biopharmaceutical company. It is engaged in the development of gene silencing therapies with its synthetic antisense oligonucleotides. Its Patrol platform is focused on the development of drugs for rare genetic diseases such as Huntington's Disease, Myotonic Dystrophy and Familial Parkinson's Disease among others.

NeuBase Therapeutics (STU:O7P) Headlines

No Headlines